Halberd Corp (HALB)
0.0089
0.00 (0.00%)
USD |
OTCM |
May 22, 15:35
Halberd Max Drawdown (5Y): 95.79% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 95.79% |
March 31, 2024 | 95.79% |
February 29, 2024 | 95.79% |
January 31, 2024 | 95.79% |
December 31, 2023 | 95.79% |
November 30, 2023 | 95.38% |
October 31, 2023 | 95.38% |
September 30, 2023 | 95.38% |
August 31, 2023 | 95.38% |
July 31, 2023 | 95.38% |
June 30, 2023 | 95.79% |
May 31, 2023 | 96.32% |
April 30, 2023 | 96.84% |
March 31, 2023 | 96.84% |
February 28, 2023 | 96.84% |
January 31, 2023 | 96.96% |
December 31, 2022 | 96.96% |
November 30, 2022 | 97.18% |
October 31, 2022 | 97.95% |
September 30, 2022 | 98.25% |
August 31, 2022 | 98.44% |
July 31, 2022 | 98.67% |
June 30, 2022 | 98.67% |
May 31, 2022 | 99.29% |
April 30, 2022 | 99.29% |
Date | Value |
---|---|
March 31, 2022 | 99.50% |
February 28, 2022 | 99.50% |
January 31, 2022 | 99.50% |
December 31, 2021 | 99.50% |
November 30, 2021 | 99.57% |
October 31, 2021 | 99.57% |
September 30, 2021 | 99.71% |
August 31, 2021 | 99.71% |
July 31, 2021 | 99.86% |
June 30, 2021 | 99.86% |
May 31, 2021 | 99.87% |
April 30, 2021 | 99.87% |
March 31, 2021 | 99.87% |
February 28, 2021 | 99.87% |
January 31, 2021 | 99.87% |
December 31, 2020 | 99.87% |
November 30, 2020 | 99.87% |
October 31, 2020 | 99.87% |
September 30, 2020 | 99.87% |
August 31, 2020 | 99.87% |
July 31, 2020 | 99.87% |
June 30, 2020 | 99.87% |
May 31, 2020 | 99.87% |
April 30, 2020 | 99.87% |
March 31, 2020 | 99.87% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.38%
Minimum
Jul 2023
99.87%
Maximum
May 2019
98.55%
Average
99.57%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
CEL-SCI Corp | 96.13% |
AIM ImmunoTech Inc | 99.76% |
IGC Pharma Inc | 97.77% |
NovaBay Pharmaceuticals Inc | 99.91% |
Protalix BioTherapeutics Inc | 94.35% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 84.94 |
Beta (5Y) | -3.716 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 374.3% |
Historical Sharpe Ratio (5Y) | 0.1163 |
Historical Sortino (5Y) | 1.052 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.33% |